Accessibility links

Breaking News

Senegal Selected for Vaccine Production

FILE - In this Tuesday, Feb. 23, 2021, photo, a health worker holds a box containing a dose of China's Sinopharm vaccine during the start of the vaccination campaign against the COVID-19 at the Health Ministry in Dakar, Senegal.

The Coalition for Epidemic Preparedness (CEPI) will invest up to $50 million over 10 years to help Senegal's Institut Pasteur manufacture vaccines for the Global South, it said on Thursday.

"The facility will ensure regional outbreaks are not neglected by deploying the latest technology for the greatest need," said Amadou Alpha Sall, CEO of Institut Pasteur de Dakar, a non-profit foundation in Senegal's capital.

CEPI, a global initiative headquartered in Norway, is creating a network of vaccine manufacturers in developing countries to help boost capacity and reserves for future outbreaks and pandemics.

At the height of the COVID-19 pandemic, a number of African nations complained that they were not able to get sufficient vaccine doses from suppliers, sparking calls for the continent to develop its own network of vaccine makers.